You have 9 free searches left this month | for more free features.

interferon-alpha

Showing 1 - 25 of 4,958

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)

Recruiting
  • Cervical Dysplasia
  • HPV Infection
  • gel Interferon arm
  • gel Interferon and interferon suppository arm
  • Ulaanbaatar, Mongolia
    National Cancer Center
Nov 14, 2023

HPV Infection Trial (Human interferon alpha 2b vaginal Effervescent capsules)

Not yet recruiting
  • HPV Infection
  • Human interferon alpha 2b vaginal Effervescent capsules
  • (no location specified)
May 8, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before

Not yet recruiting
  • Herpes Zoster
  • Recombinant Human Interferon α-2b Gel (After the Alteration)
  • Recombinant Human Interferon α-2b Gel (Before the Alteration)
  • (no location specified)
Apr 7, 2023

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 18, 2022

Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

Not yet recruiting
  • Myelofibrosis
  • Pegylated interferon alpha2a
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 6, 2022

COVID-19 Infection and Its Clinical Prognosis in Chronic

Recruiting
  • Chronic Hepatitis B
  • COVID-19 Infection
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

Terminated
  • Hepatitis B, Chronic
  • Hillsborough, New Jersey
  • +11 more
Dec 28, 2022

Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

Recruiting
  • Polycythemia Vera
  • London, United Kingdom
  • +1 more
Nov 29, 2021

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2022

Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes

Recruiting
  • Toxicity, Drug
  • +2 more
  • Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 16, 2022

Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon

Active, not recruiting
  • HIV
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Coronavirus Disease 2019 Trial in Santiago (Interferon-Alpha2B, Placebo)

    Completed
    • Coronavirus Disease 2019
    • Santiago, RM, Chile
      Red de Salud UC Christus
    Aug 3, 2022

    Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

    Completed
    • Sarcoma, Kaposi
    • HIV Infections
    • Interferon alfa-2a
    • +2 more
    • Miami, Florida
      Univ of Miami School of Medicine
    Oct 27, 2021

    Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

    Completed
    • Sarcoma, Kaposi
    • HIV Infections
    • Interferon alfa-2a
    • +2 more
    • New York, New York
      Mem Sloan - Kettering Cancer Ctr
    Oct 28, 2021

    Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

    Not yet recruiting
    • Angiosarcoma
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 23, 2023

    Neuroendocrine Tumors Trial in Besancon, Montbéliard (Metronomic cyclophosphamide, Interferon-alpha)

    Completed
    • Neuroendocrine Tumors
    • Metronomic cyclophosphamide
    • Interferon-alpha
    • Besancon, France
    • +1 more
    Jul 30, 2021

    Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

    Active, not recruiting
    • Lymphoproliferative Disorder
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)

    Active, not recruiting
    • Chronic Hepatitis B
    • Birtinya, Queensland, Australia
    • +21 more
    Dec 20, 2021

    Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

    Completed
    • Metastatic Carcinoma in the Liver
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Feb 25, 2022

    Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

    Completed
    • Juvenile Pilocytic Astrocytomas
    • Optic Pathway Gliomas
    • Pegylated interferon alpha-2b
    • Atlanta, Georgia
      Children's Healthcare of Atlanta
    Jan 18, 2022

    Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

    Recruiting
    • Stage III Hepatocellular Carcinoma AJCC v8
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 18, 2021

    Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

    Recruiting
    • Hematological Neoplasms
    • Recurrence
    • Peg interferon alfa-2b
    • Shanghai, Shanghai, China
      Shanghai Jiao Tong University Affilated First People's Hospital
    Oct 10, 2021